APPB - Applied Biosciences Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
2.0000
0.0000 (0.00%)
At close: 3:47PM EST
Stock chart is not supported by your current browser
Previous Close2.0000
Open1.8500
Bid0.00 x 0
Ask0.00 x 0
Day's Range1.8400 - 2.0000
52 Week Range0.7000 - 2.9500
Volume2,439
Avg. Volume2,981
Market Cap26.684M
Beta (3Y Monthly)0.04
PE Ratio (TTM)N/A
EPS (TTM)-0.34
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire12 days ago

    Applied BioSciences Receives Distribution from Investment in JUUL

    LOS ANGELES, Feb. 05, 2019 -- Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health.

  • GlobeNewswire24 days ago

    Applied BioSciences Expands Scientific Advisory Board

    Applied BioSciences Corp. (APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that Dr. Xiang-Qun (Sean) Xie has joined its Scientific Advisory Board. The company continues to add professionals who are expert in relevant fields, such as scientific research and development, FDA procedures and medicine.  These professionals will provide the company with an outstanding base of knowledge and experience to build on and advance the development of additional products.  With the addition of several prominent scientists and physicians and their knowledge base, clinical trials, product development, and design procedures for submitting products to the FDA can be done in an expedited time frame.

  • GlobeNewswirelast month

    Applied BioSciences Acquires Majority Stake in Cannabis Testing Firm

    Applied Biosciences Corp. (APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that it has acquired a majority stake in Trace Analytics, Inc., a leading testing and analytics company. Although the health benefits of Cannabis and CBD are becoming well known, one of the challenges is the safety and testing of these products which are ingested, vaped and applied topically.  Many products in the market are cheaply-made, with multiple toxins, chemicals and synthetics.   Some of the products include high levels of THC, harmful substances, illegally processed synthetic cannabinoids, and even some that have no CBD at all. Applied Biosciences intends to position Trace as the leading provider of testing solutions for both compliance requirements and consumer safety.

  • GlobeNewswirelast month

    Applied BioSciences Withdraws Equity Offering after Passing of Farm Bill

    Applied BioSciences Corp. (APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that it has withdrawn its Registration Statement filed on December 3, 2018 and will not sell any securities under the Common Stock Purchase Agreement related to the Registration Statement. On December 20, 2018, President Trump signed the US Farm Bill into law. The new law defines hemp as an agricultural product for the first time in 50 years and allows American farmers to plant and harvest hemp.

  • ACCESSWIRE3 months ago

    Applied BioSciences to Present at the 11th Annual LD Micro Main Event

    LOS ANGELES, CA / ACCESSWIRE / November 27, 2018 / Applied BioSciences Corp., a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that it will be presenting at the 11th Annual LD Micro Main Event on December 4th at 5:30pm PST. The LD Micro Main Event will take place December 4th, 5th, and 6th, in Los Angeles at the Luxe Sunset Bel Air Hotel, will feature 250 companies, and will be attended by over 1,200 individuals. Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry.

  • ACCESSWIRE3 months ago

    Uptick Newswire interviews Applied BioSciences for The First time on the Stock Day Radio podcast and Discuses the Growth of Their CBD Product Lines

    LOS ANGELES, CA / ACCESSWIRE / November 26, 2018 / Applied BioSciences Corp. (APPB) is a diversified cannabinoid therapeutics company that specializes in the medical,bioceutical, and pet health industries. The President of Applied BioSciences, Chris Bridges, joined Stock Day's Everett Jolly for the first time to discuss the Company's newly expanded product line, as well as their goals for growth going forward. Jolly began the interview by asking Bridges for a little bit of background information on the Company, as well as himself.

  • ACCESSWIRE3 months ago

    Applied BioSciences Enters the Vape Inhaler Market

    LOS ANGELES, CA / ACCESSWIRE / November 7, 2018 / Applied BioSciences Corp. (APPB), a diversified cannabinoid therapeutics company focused on the medical,bioceutical and pet health industries, announced that it has expanded its product line and launched an alternative vape inhaler technology using water vapor and natural flavors. The Remedi Plus Therapeutic Vapor Inhaler contains a revolutionary recipe of steam-distilled essential oils and flower essences uniquely blended with CBD Isolate. The Remedi Plus product line has been crafted with just simple flavored waters by nature and blended with CBD in vapor form.

  • ACCESSWIRE8 months ago

    Applied BioSciences Launches Patented New Product CanaGel(TM)

    LOS ANGELES, CA / ACCESSWIRE / June 19, 2018 / Applied BioSciences Corp. (APPB) (the "Company"), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, today announced that the Company has entered into a marketing and distribution agreement with CanaGel™ to launch their first patent-protected product, Hemp Oil Gel Melts. The Company continues to increase sales of hemp-derived products through its wholly owned divisions, Remedi and TherPet, and is now pleased to report that it will be adding the patented CanaGel™ Hemp Oil Gel Melts to its comprehensive suite of product offerings. "Since all CanaGel™ products are non-GMO, vegan, paleo, gluten-free, and sugar-free, we knew that consumers would be interested in an exciting new alternative to the existing oils, capsules, edibles and chewables on the market," commented Chris Bridges, President of Applied BioSciences Corp.

  • ACCESSWIRE9 months ago

    Applied BioSciences Expands TherPet Line with Equine Care Line

    LOS ANGELES, CA / ACCESSWIRE / May 9, 2018 / Applied BioSciences Corp. (APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, today announced that the Company's wholly-owned animal health subsidiary TherPet has entered the equine health space with the launch of a new full-spectrum hemp-derived cannabidiol ("CBD") supplement formulated specifically for a horse's health and wellness. TherPet's Equine Care CBD line is a natural supplement designed to play a key role in keeping horses, healthy, looking good and performing their best. Like humans, horses also have an endocannabinoid system comprised of cannabinoid receptors that help regulate a wide variety of bodily functions ranging from pain relief to mood.

  • ACCESSWIRE10 months ago

    Applied BioSciences Expands Distribution through LeafLink

    LOS ANGELES, CA / ACCESSWIRE / April 17, 2018 / Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, today ...

  • ACCESSWIRE10 months ago

    Applied Biosciences Launches New Line of CBD Products

    LOS ANGELES, CA / ACCESSWIRE / April 10, 2018 / Applied Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced ...

  • ACCESSWIRE11 months ago

    Applied Biosciences Finalizes Name and Ticker Change

    LOS ANGELES, CA / ACCESSWIRE / April 2, 2018 / Applied Biosciences Corp. (OTCQB: APPB), formerly known as Stony Hill Corp., a diversified cannabinoid therapeutics company focused on the medical, bioceutical ...